Bassem I Yamout

Summary

Affiliation: Saint Joseph University
Country: Lebanon

Publications

  1. doi Adherence to disease-modifying drugs in patients with multiple sclerosis: a consensus statement from the Middle East MS Advisory Group
    Bassem I Yamout
    Internal Medicine, American University of Beirut, Beirut, Lebanon
    Int J Neurosci 120:273-9. 2010
  2. doi Predictors of quality of life among multiple sclerosis patients: a comprehensive analysis
    B Yamout
    Department of Neurology, American University of Beirut, Beirut, Lebanon
    Eur J Neurol 20:756-64. 2013
  3. ncbi Successful treatment of refractory neuroSjogren with Rituximab
    B Yamout
    Department of Internal Medicine, Faculty of Medicine, American University of Beirut, Beirut, Lebanon
    Lupus 16:521-3. 2007
  4. doi Clinical characteristics of multiple sclerosis in Lebanon
    B Yamout
    Department of Internal Medicine, Faculty of Medicine, American University of Beirut Medical Center, Lebanon
    J Neurol Sci 270:88-93. 2008
  5. doi Prognostic factors of multiple sclerosis in Lebanon
    Bassem Yamout
    Department of Neurology, American University of Beirut Medical Center, Beirut, Lebanon
    Int J Neurosci 120:206-10. 2010
  6. doi Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study
    Bassem Yamout
    Departments of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
    J Neuroimmunol 227:185-9. 2010
  7. doi Extracranial venous stenosis is an unlikely cause of multiple sclerosis
    Bassem Yamout
    Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
    Mult Scler 16:1341-8. 2010
  8. doi Motor variant of chronic inflammatory demyelinating polyneuropathy in a child
    Durriyah D Sinno
    Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon
    Pediatr Neurol 38:426-9. 2008

Collaborators

Detail Information

Publications8

  1. doi Adherence to disease-modifying drugs in patients with multiple sclerosis: a consensus statement from the Middle East MS Advisory Group
    Bassem I Yamout
    Internal Medicine, American University of Beirut, Beirut, Lebanon
    Int J Neurosci 120:273-9. 2010
    ..The group debated several key questions about the features and causes of patient nonadherence and its management. Further, they made recommendations for optimizing treatment adherence in this area...
  2. doi Predictors of quality of life among multiple sclerosis patients: a comprehensive analysis
    B Yamout
    Department of Neurology, American University of Beirut, Beirut, Lebanon
    Eur J Neurol 20:756-64. 2013
    ..However, no study assessed the role of the different demographic, clinical, physical, social, economic and psychological parameters in the perception of patients with MS of their QOL...
  3. ncbi Successful treatment of refractory neuroSjogren with Rituximab
    B Yamout
    Department of Internal Medicine, Faculty of Medicine, American University of Beirut, Beirut, Lebanon
    Lupus 16:521-3. 2007
    ..Rituximab may be considered as an effective and promising novel therapy in SS patients with neurological involvement...
  4. doi Clinical characteristics of multiple sclerosis in Lebanon
    B Yamout
    Department of Internal Medicine, Faculty of Medicine, American University of Beirut Medical Center, Lebanon
    J Neurol Sci 270:88-93. 2008
    ..Although some of the clinical characteristics of our MS population were different compared to western series, the natural history of the disease was similar...
  5. doi Prognostic factors of multiple sclerosis in Lebanon
    Bassem Yamout
    Department of Neurology, American University of Beirut Medical Center, Beirut, Lebanon
    Int J Neurosci 120:206-10. 2010
    ..Most of the data on these factors however comes from studies performed in western countries. Such data is lacking in the Arab World. The objective of this study is to identify early predictors of disability among MS patients in Lebanon...
  6. doi Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study
    Bassem Yamout
    Departments of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
    J Neuroimmunol 227:185-9. 2010
    ..Vision and low contrast sensitivity testing at 3 months showed improvement in 5/6 and worsening in 1/6 patients. Early results show hints of clinical but not radiological efficacy and evidence of safety with no serious adverse events...
  7. doi Extracranial venous stenosis is an unlikely cause of multiple sclerosis
    Bassem Yamout
    Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
    Mult Scler 16:1341-8. 2010
    ..Extracranial venous stenosis (EVS) has recently been implicated as the primary cause of multiple sclerosis (MS). Objective: The aim of this study was to determine the presence of EVS in MS patients...
  8. doi Motor variant of chronic inflammatory demyelinating polyneuropathy in a child
    Durriyah D Sinno
    Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon
    Pediatr Neurol 38:426-9. 2008
    ....